AIM ImmunoTech Inc.
AIM
$0.1193
-$0.0007-0.58%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.93M | -28.05M | -31.12M | -28.96M | -20.78M |
| Total Depreciation and Amortization | 240.00K | 230.00K | 249.00K | 238.00K | 350.00K |
| Total Amortization of Deferred Charges | 232.00K | 270.00K | 73.00K | -- | -- |
| Total Other Non-Cash Items | 1.80M | 1.78M | 770.00K | 326.00K | 704.00K |
| Change in Net Operating Assets | 963.00K | 2.51M | 7.62M | 7.13M | 2.14M |
| Cash from Operations | -20.69M | -23.25M | -22.40M | -21.27M | -17.58M |
| Capital Expenditure | -8.00K | 0.00 | 0.00 | 0.00 | -396.00K |
| Sale of Property, Plant, and Equipment | 47.00K | 12.00K | 18.00K | 47.00K | 3.90M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 749.00K | 106.00K | -930.00K | -879.00K | -759.00K |
| Cash from Investing | 788.00K | 118.00K | -912.00K | -832.00K | 2.75M |
| Total Debt Issued | 2.50M | 2.37M | 2.50M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.01M | 1.24M | 714.00K | 485.00K | 338.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.05M | 2.05M | -- | -- | -- |
| Cash from Financing | 5.55M | 5.65M | 3.21M | 485.00K | 338.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.35M | -17.48M | -20.10M | -21.61M | -14.50M |
